These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 12997260

  • 21. The activation of human plasminogen. II. A kinetic study of activation with trypsin, urokinase, and streptokinase.
    ALKJAERSIG N, FLETCHER AP, SHERRY S.
    J Biol Chem; 1958 Jul; 233(1):86-90. PubMed ID: 13563446
    [No Abstract] [Full Text] [Related]

  • 22. Variations in serum lipids with fibrinolytic and proteolytic activity in dogs and rabbits.
    BANG NU, CLIFFTON EE.
    Am J Physiol; 1961 Feb; 200():323-6. PubMed ID: 13686573
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Inhibition of clotting as the result of plasminogen activation by streptokinase. 2. Analytical studies of the clotting mechanism.
    BELLER FK, GLAS P.
    Thromb Diath Haemorrh; 1960 Jun 15; 4():520-33. PubMed ID: 13798543
    [No Abstract] [Full Text] [Related]

  • 25. Studies on the mechanism of bovine plasminogen activation by human plasmin and streptokinase.
    ZYLBER J, BLATT WF, JENSEN H.
    Rep US Army Med Res Lab; 1959 Sep 14; ():1-12. PubMed ID: 13847996
    [No Abstract] [Full Text] [Related]

  • 26. Mechanism of bovine plasminogen activation by human plasmin and streptokinase.
    ZYLBER J, BLATT WF, JENSEN H.
    Proc Soc Exp Biol Med; 1959 Sep 14; 102():755-61. PubMed ID: 13847995
    [No Abstract] [Full Text] [Related]

  • 27. [THROMBOLYTIC THERAPY].
    ISIDORI A.
    Rass Fisiopatol Clin Ter; 1964 Sep 14; 36():219-27. PubMed ID: 14174161
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [PRELIMINARY STUDIES ON HUMORAL FACTORS IN RHEUMATOID ARTHRITIS].
    BREWER EJ, FAHLBERG WJ.
    Rev Med Chil; 1964 Mar 14; 92():191-3. PubMed ID: 14169683
    [No Abstract] [Full Text] [Related]

  • 37. Proteolytic activity of whole human serum activated by streptokinase.
    MEYERS WM, BURDON KL.
    Arch Biochem Biophys; 1956 May 14; 62(1):6-15. PubMed ID: 13314633
    [No Abstract] [Full Text] [Related]

  • 38. [Treatment of patients with inflammatory changes of the deep portion of the lacrimal duct with proteolytic enzyme lavage (streptokinase and streptodornase); preliminary note].
    DE BARROS JA, SIQUEIRA N.
    Hospital (Rio J); 1959 Aug 14; 56():349-50. PubMed ID: 13797109
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of experimental total hyphema with intraocular fibrinolytic agents.
    LIEBMAN SD, POLLEN A, PODOS SM.
    Arch Ophthalmol; 1962 Jul 14; 68():72-8. PubMed ID: 14465192
    [No Abstract] [Full Text] [Related]

  • 40. Experimental hyphema in rabbits. IV. The effect of fibrinolytic enzymes on the rate of absorption.
    SINSKEY RM, KRICHESKY AR.
    Am J Ophthalmol; 1962 Sep 14; 54():445-50. PubMed ID: 13913402
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.